Know Cancer

or
forgot password

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples


N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer, Ovarian Cancer, Gynecologic Cancers, Ovarian/Peritoneal/Fallopian Cancer

Thank you

Trial Information

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples


Inclusion Criteria:



I. Women who have a high risk of developing breast or ovarian cancer due to a known
germline mutation in the BRCA1/2, PTEN, CDH1, or TP53 cancer susceptibility genes, or due
to strong family history of either breast or ovarian cancer, in the absence of known
cancer susceptibility gene mutation.

II. Women who are approaching surgery for resection of a pelvic mass, which is considered
suspicious for neoplasia by radiologic or clinical criteria; such women may or may not
also meet criteria for inclusion in group I.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

James M Ford

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

BRSNSTU0020

NCT ID:

NCT01034033

Start Date:

August 2001

Completion Date:

December 2015

Related Keywords:

  • Breast Cancer
  • Ovarian Cancer
  • Gynecologic Cancers
  • Ovarian/Peritoneal/Fallopian Cancer
  • quality of life
  • Breast Neoplasms
  • Ovarian Neoplasms

Name

Location

Stanford University School of MedicineStanford, California  94305-5317